Intrinsic value of Chemours - CC

Previous Close

$39.84

  Intrinsic Value

$0.98

stock screener

  Rating & Target

str. sell

-98%

Previous close

$39.84

 
Intrinsic value

$0.98

 
Up/down potential

-98%

 
Rating

str. sell

We calculate the intrinsic value of CC stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Shares outstanding, mln

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  -5.54
  14.40
  13.46
  12.61
  11.85
  11.17
  10.55
  10.00
  9.50
  9.05
  8.64
  8.28
  7.95
  7.65
  7.39
  7.15
  6.94
  6.74
  6.57
  6.41
  6.27
  6.14
  6.03
  5.93
  5.83
  5.75
  5.67
  5.61
  5.55
  5.49
  5.44
Revenue, $m
  5,400
  7,073
  8,025
  9,038
  10,109
  11,238
  12,424
  13,665
  14,963
  16,317
  17,727
  19,194
  20,720
  22,306
  23,954
  25,667
  27,447
  29,298
  31,222
  33,223
  35,306
  37,475
  39,734
  42,089
  44,544
  47,105
  49,778
  52,570
  55,485
  58,533
  61,718
Variable operating expenses, $m
 
  7,170
  8,133
  9,157
  10,240
  11,382
  12,581
  13,837
  15,149
  16,518
  17,944
  19,411
  20,954
  22,558
  24,225
  25,957
  27,758
  29,629
  31,575
  33,599
  35,706
  37,899
  40,184
  42,565
  45,048
  47,638
  50,342
  53,164
  56,113
  59,195
  62,417
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  5,474
  7,170
  8,133
  9,157
  10,240
  11,382
  12,581
  13,837
  15,149
  16,518
  17,944
  19,411
  20,954
  22,558
  24,225
  25,957
  27,758
  29,629
  31,575
  33,599
  35,706
  37,899
  40,184
  42,565
  45,048
  47,638
  50,342
  53,164
  56,113
  59,195
  62,417
Operating income, $m
  -74
  -97
  -107
  -119
  -131
  -144
  -157
  -171
  -186
  -201
  -217
  -217
  -234
  -252
  -271
  -290
  -311
  -332
  -353
  -376
  -399
  -424
  -450
  -476
  -504
  -533
  -563
  -595
  -628
  -662
  -698
EBITDA, $m
  210
  224
  255
  287
  321
  356
  394
  433
  475
  518
  562
  609
  657
  708
  760
  814
  871
  929
  990
  1,054
  1,120
  1,189
  1,260
  1,335
  1,413
  1,494
  1,579
  1,668
  1,760
  1,857
  1,958
Interest expense (income), $m
  208
  230
  282
  337
  396
  459
  525
  594
  666
  742
  820
  903
  988
  1,077
  1,169
  1,265
  1,365
  1,469
  1,576
  1,689
  1,805
  1,926
  2,053
  2,184
  2,322
  2,465
  2,614
  2,769
  2,932
  3,102
  3,279
Earnings before tax, $m
  -11
  -327
  -389
  -456
  -527
  -603
  -682
  -765
  -852
  -943
  -1,038
  -1,120
  -1,222
  -1,329
  -1,440
  -1,556
  -1,676
  -1,800
  -1,930
  -2,064
  -2,205
  -2,350
  -2,502
  -2,661
  -2,826
  -2,998
  -3,177
  -3,364
  -3,560
  -3,764
  -3,978
Tax expense, $m
  -18
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Net income, $m
  7
  -327
  -389
  -456
  -527
  -603
  -682
  -765
  -852
  -943
  -1,038
  -1,120
  -1,222
  -1,329
  -1,440
  -1,556
  -1,676
  -1,800
  -1,930
  -2,064
  -2,205
  -2,350
  -2,502
  -2,661
  -2,826
  -2,998
  -3,177
  -3,364
  -3,560
  -3,764
  -3,978

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  902
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,060
  8,341
  9,464
  10,658
  11,921
  13,252
  14,650
  16,115
  17,645
  19,241
  20,904
  22,634
  24,434
  26,304
  28,248
  30,268
  32,367
  34,549
  36,818
  39,178
  41,635
  44,192
  46,857
  49,633
  52,528
  55,549
  58,701
  61,992
  65,431
  69,024
  72,781
Adjusted assets (=assets-cash), $m
  5,158
  8,341
  9,464
  10,658
  11,921
  13,252
  14,650
  16,115
  17,645
  19,241
  20,904
  22,634
  24,434
  26,304
  28,248
  30,268
  32,367
  34,549
  36,818
  39,178
  41,635
  44,192
  46,857
  49,633
  52,528
  55,549
  58,701
  61,992
  65,431
  69,024
  72,781
Revenue / Adjusted assets
  1.047
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
  0.848
Average production assets, $m
  2,994
  3,409
  3,868
  4,356
  4,873
  5,417
  5,988
  6,587
  7,212
  7,865
  8,544
  9,251
  9,987
  10,751
  11,546
  12,372
  13,230
  14,121
  15,049
  16,014
  17,018
  18,063
  19,152
  20,287
  21,470
  22,705
  23,993
  25,339
  26,744
  28,213
  29,748
Working capital, $m
  782
  347
  393
  443
  495
  551
  609
  670
  733
  800
  869
  941
  1,015
  1,093
  1,174
  1,258
  1,345
  1,436
  1,530
  1,628
  1,730
  1,836
  1,947
  2,062
  2,183
  2,308
  2,439
  2,576
  2,719
  2,868
  3,024
Total debt, $m
  3,544
  5,036
  6,026
  7,079
  8,193
  9,367
  10,601
  11,892
  13,242
  14,650
  16,116
  17,643
  19,230
  20,879
  22,594
  24,375
  26,227
  28,151
  30,153
  32,234
  34,401
  36,657
  39,006
  41,455
  44,009
  46,673
  49,453
  52,356
  55,389
  58,558
  61,872
Total liabilities, $m
  5,960
  7,357
  8,347
  9,400
  10,514
  11,688
  12,922
  14,213
  15,563
  16,971
  18,437
  19,964
  21,551
  23,200
  24,915
  26,696
  28,548
  30,472
  32,474
  34,555
  36,722
  38,978
  41,327
  43,776
  46,330
  48,994
  51,774
  54,677
  57,710
  60,879
  64,193
Total equity, $m
  100
  984
  1,117
  1,258
  1,407
  1,564
  1,729
  1,902
  2,082
  2,270
  2,467
  2,671
  2,883
  3,104
  3,333
  3,572
  3,819
  4,077
  4,345
  4,623
  4,913
  5,215
  5,529
  5,857
  6,198
  6,555
  6,927
  7,315
  7,721
  8,145
  8,588
Total liabilities and equity, $m
  6,060
  8,341
  9,464
  10,658
  11,921
  13,252
  14,651
  16,115
  17,645
  19,241
  20,904
  22,635
  24,434
  26,304
  28,248
  30,268
  32,367
  34,549
  36,819
  39,178
  41,635
  44,193
  46,856
  49,633
  52,528
  55,549
  58,701
  61,992
  65,431
  69,024
  72,781
Debt-to-equity ratio
  35.440
  5.120
  5.400
  5.630
  5.820
  5.990
  6.130
  6.250
  6.360
  6.450
  6.530
  6.610
  6.670
  6.730
  6.780
  6.820
  6.870
  6.910
  6.940
  6.970
  7.000
  7.030
  7.050
  7.080
  7.100
  7.120
  7.140
  7.160
  7.170
  7.190
  7.200
Adjusted equity ratio
  -0.155
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118
  0.118

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  7
  -327
  -389
  -456
  -527
  -603
  -682
  -765
  -852
  -943
  -1,038
  -1,120
  -1,222
  -1,329
  -1,440
  -1,556
  -1,676
  -1,800
  -1,930
  -2,064
  -2,205
  -2,350
  -2,502
  -2,661
  -2,826
  -2,998
  -3,177
  -3,364
  -3,560
  -3,764
  -3,978
Depreciation, amort., depletion, $m
  284
  321
  362
  406
  452
  500
  551
  605
  661
  719
  779
  826
  892
  960
  1,031
  1,105
  1,181
  1,261
  1,344
  1,430
  1,519
  1,613
  1,710
  1,811
  1,917
  2,027
  2,142
  2,262
  2,388
  2,519
  2,656
Funds from operations, $m
  1,078
  -6
  -27
  -51
  -76
  -102
  -130
  -160
  -191
  -224
  -258
  -294
  -331
  -369
  -409
  -451
  -494
  -539
  -586
  -635
  -685
  -738
  -792
  -849
  -909
  -970
  -1,035
  -1,102
  -1,172
  -1,245
  -1,322
Change in working capital, $m
  484
  44
  47
  50
  52
  55
  58
  61
  64
  66
  69
  72
  75
  78
  81
  84
  87
  91
  94
  98
  102
  106
  111
  115
  120
  125
  131
  137
  143
  149
  156
Cash from operations, $m
  594
  -50
  -74
  -100
  -128
  -158
  -189
  -221
  -255
  -290
  -327
  -366
  -406
  -447
  -490
  -535
  -582
  -630
  -680
  -733
  -787
  -844
  -903
  -965
  -1,029
  -1,096
  -1,166
  -1,239
  -1,315
  -1,394
  -1,478
Maintenance CAPEX, $m
  0
  -266
  -304
  -345
  -389
  -435
  -484
  -535
  -588
  -644
  -702
  -763
  -826
  -892
  -960
  -1,031
  -1,105
  -1,181
  -1,261
  -1,344
  -1,430
  -1,519
  -1,613
  -1,710
  -1,811
  -1,917
  -2,027
  -2,142
  -2,262
  -2,388
  -2,519
New CAPEX, $m
  -338
  -429
  -459
  -488
  -516
  -544
  -571
  -599
  -625
  -652
  -680
  -707
  -735
  -764
  -794
  -826
  -858
  -892
  -927
  -965
  -1,004
  -1,045
  -1,089
  -1,135
  -1,183
  -1,234
  -1,288
  -1,345
  -1,405
  -1,469
  -1,536
Cash from investing activities, $m
  357
  -695
  -763
  -833
  -905
  -979
  -1,055
  -1,134
  -1,213
  -1,296
  -1,382
  -1,470
  -1,561
  -1,656
  -1,754
  -1,857
  -1,963
  -2,073
  -2,188
  -2,309
  -2,434
  -2,564
  -2,702
  -2,845
  -2,994
  -3,151
  -3,315
  -3,487
  -3,667
  -3,857
  -4,055
Free cash flow, $m
  951
  -745
  -837
  -934
  -1,034
  -1,137
  -1,244
  -1,354
  -1,468
  -1,587
  -1,709
  -1,836
  -1,967
  -2,103
  -2,245
  -2,391
  -2,544
  -2,703
  -2,869
  -3,041
  -3,221
  -3,409
  -3,605
  -3,810
  -4,024
  -4,247
  -4,481
  -4,726
  -4,983
  -5,251
  -5,532
Issuance/(repayment) of debt, $m
  -381
  924
  990
  1,053
  1,114
  1,174
  1,233
  1,292
  1,350
  1,408
  1,467
  1,526
  1,587
  1,650
  1,714
  1,781
  1,851
  1,925
  2,001
  2,082
  2,167
  2,256
  2,350
  2,449
  2,554
  2,664
  2,780
  2,903
  3,033
  3,169
  3,314
Issuance/(repurchase) of shares, $m
  11
  451
  522
  597
  676
  760
  847
  938
  1,032
  1,131
  1,234
  1,324
  1,435
  1,550
  1,670
  1,794
  1,923
  2,058
  2,197
  2,343
  2,494
  2,652
  2,817
  2,988
  3,167
  3,354
  3,549
  3,753
  3,966
  4,188
  4,421
Cash from financing (excl. dividends), $m  
  -374
  1,375
  1,512
  1,650
  1,790
  1,934
  2,080
  2,230
  2,382
  2,539
  2,701
  2,850
  3,022
  3,200
  3,384
  3,575
  3,774
  3,983
  4,198
  4,425
  4,661
  4,908
  5,167
  5,437
  5,721
  6,018
  6,329
  6,656
  6,999
  7,357
  7,735
Total cash flow (excl. dividends), $m
  558
  630
  675
  716
  757
  797
  836
  875
  914
  952
  991
  1,014
  1,055
  1,096
  1,139
  1,184
  1,231
  1,279
  1,330
  1,384
  1,440
  1,499
  1,562
  1,628
  1,697
  1,771
  1,848
  1,930
  2,016
  2,106
  2,202
Retained Cash Flow (-), $m
  26
  -451
  -522
  -597
  -676
  -760
  -847
  -938
  -1,032
  -1,131
  -1,234
  -1,324
  -1,435
  -1,550
  -1,670
  -1,794
  -1,923
  -2,058
  -2,197
  -2,343
  -2,494
  -2,652
  -2,817
  -2,988
  -3,167
  -3,354
  -3,549
  -3,753
  -3,966
  -4,188
  -4,421
Prev. year cash balance distribution, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  179
  153
  119
  81
  37
  -11
  -63
  -119
  -179
  -242
  -310
  -380
  -454
  -530
  -610
  -693
  -779
  -867
  -959
  -1,055
  -1,153
  -1,255
  -1,361
  -1,470
  -1,583
  -1,701
  -1,823
  -1,950
  -2,082
  -2,219
Discount rate, %
 
  7.40
  7.77
  8.16
  8.57
  8.99
  9.44
  9.92
  10.41
  10.93
  11.48
  12.05
  12.66
  13.29
  13.95
  14.65
  15.38
  16.15
  16.96
  17.81
  18.70
  19.63
  20.62
  21.65
  22.73
  23.87
  25.06
  26.31
  27.63
  29.01
  30.46
PV of cash for distribution, $m
 
  167
  132
  94
  58
  24
  -6
  -32
  -54
  -70
  -82
  -89
  -91
  -90
  -85
  -78
  -70
  -61
  -52
  -43
  -34
  -27
  -20
  -15
  -11
  -8
  -5
  -3
  -2
  -1
  -1
Current shareholders' claim on cash, %
  100
  94.0
  88.3
  82.9
  77.8
  72.9
  68.4
  64.2
  60.2
  56.4
  52.9
  49.7
  46.6
  43.7
  41.1
  38.5
  36.1
  33.9
  31.8
  29.9
  28.0
  26.3
  24.7
  23.1
  21.7
  20.4
  19.1
  17.9
  16.8
  15.8
  14.8

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment is a North American provider of industrial chemicals used in gold production, oil and gas, water treatment and other industries. It delivers customized solutions with a range of industrial and specialty chemical products for markets, including plastics and coatings, refrigeration and air conditioning, industrial, mining and oil refining. Its products include titanium dioxide, refrigerants, industrial fluoropolymer resins and a portfolio of mining and industrial chemicals, including sodium cyanide. As of December 31, 2016, the Company operates 26 production facilities located in 10 countries.

FINANCIAL RATIOS  of  Chemours (CC)

Valuation Ratios
P/E Ratio 1039.3
Price to Sales 1.3
Price to Book 72.7
Price to Tangible Book
Price to Cash Flow 12.2
Price to Free Cash Flow 28.4
Growth Rates
Sales Growth Rate -5.5%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate -34.9%
Cap. Spend. - 3 Yr. Gr. Rate -5.1%
Financial Strength
Quick Ratio 60
Current Ratio 0
LT Debt to Equity 3529%
Total Debt to Equity 3544%
Interest Coverage 1
Management Effectiveness
Return On Assets -2%
Ret/ On Assets - 3 Yr. Avg. 1.4%
Return On Total Capital 0.2%
Ret/ On T. Cap. - 3 Yr. Avg. 3.2%
Return On Equity 6.2%
Return On Equity - 3 Yr. Avg. 4.4%
Asset Turnover 0.9
Profitability Ratios
Gross Margin 20.6%
Gross Margin - 3 Yr. Avg. 19.5%
EBITDA Margin 8.9%
EBITDA Margin - 3 Yr. Avg. 8.2%
Operating Margin -1.4%
Oper. Margin - 3 Yr. Avg. 1.4%
Pre-Tax Margin -0.2%
Pre-Tax Margin - 3 Yr. Avg. 1.7%
Net Profit Margin 0.1%
Net Profit Margin - 3 Yr. Avg. 1.6%
Effective Tax Rate 163.6%
Eff/ Tax Rate - 3 Yr. Avg. 81%
Payout Ratio 314.3%

CC stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the CC stock intrinsic value calculation we used $6183 million for the last fiscal year's total revenue generated by Chemours. The default revenue input number comes from 2016 income statement of Chemours. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our CC stock valuation model: a) initial revenue growth rate of 14.4% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.4%, whose default value for CC is calculated based on our internal credit rating of Chemours, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Chemours.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of CC stock the variable cost ratio is equal to 101.4%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for CC stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.6% for Chemours.

Corporate tax rate of 27% is the nominal tax rate for Chemours. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the CC stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for CC are equal to 48.2%.

Life of production assets of 11.2 years is the average useful life of capital assets used in Chemours operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for CC is equal to 4.9%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $860 million for Chemours - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 176.845 million for Chemours is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Chemours at the current share price and the inputted number of shares is $7.0 billion.

RELATED COMPANIES Price Int.Val. Rating
MMM 3M 213.51 232.48  hold
HUN Huntsman 28.21 115.42  str.buy
KRO Kronos Worldwi 16.89 64.08  str.buy
OXY Occidental Pet 80.75 53.11  sell
HON Honeywell Inte 165.46 242.19  str.buy

COMPANY NEWS

▶ Chemours Finally Has the Right Mix   [Aug-28-18 12:05PM  TheStreet.com]
▶ Chemours CFO on growth in the chemicals business   [Aug-24-18 05:02PM  Yahoo Finance Video]
▶ The Key to Spotting a Value Trap   [Aug-09-18 10:31AM  Zacks]
▶ Here's Why Chemours Co. Gained as Much as 11.4% Today   [Aug-03-18 02:27PM  Motley Fool]
▶ Chemours Co. to Host Earnings Call   [06:30AM  ACCESSWIRE]
▶ Chemours: 2Q Earnings Snapshot   [05:12AM  Associated Press]
▶ 4 Reasons To Be Buyers Of Chemours, Courtesy Of RBC   [Jul-18-18 03:32PM  Benzinga]
▶ Why This Analyst Likes Chemours Stock   [11:22AM  Motley Fool]
▶ Chemical Production on the Upswing: 5 Growth Stocks to Buy   [Jul-06-18 11:10AM  InvestorPlace]
▶ Chemours Company Enters Oversold Territory   [Jun-22-18 07:12AM  Zacks]
▶ 5 Value Stocks for Market-Beating Returns   [Jun-20-18 01:25PM  InvestorPlace]
▶ Top Ranked Growth Stocks to Buy for May 29th   [May-29-18 09:27AM  Zacks]
▶ 5 Ultra Cheap PEG Stocks Value Investors Will Love   [May-15-18 12:15PM  InvestorPlace]
▶ Chemours Announces Sodium Cyanide Price Increase   [May-07-18 04:45PM  PR Newswire]
▶ Chemours Co. to Host Earnings Call   [06:00AM  ACCESSWIRE]
▶ Chemours: 1Q Earnings Snapshot   [05:03AM  Associated Press]
▶ Chemours Announces Second Quarter Dividend   [May-01-18 08:48PM  PR Newswire]
▶ 'Fast and loose': Plaintiffs respond to motion to dismiss GenX case   [Apr-16-18 02:25PM  American City Business Journals]
▶ 5 Great Basic Materials Stocks to Buy Ahead of Q1 Earnings   [Apr-10-18 01:15PM  InvestorPlace]
▶ Ex-DuPont workers say Chemours Co. tricked them out of money   [Apr-06-18 07:01AM  Associated Press]
▶ Top Ranked Value Stocks to Buy for April 5th   [Apr-05-18 06:40AM  Zacks]
▶ Chemours Announces Fluoropolymer Price Increase   [Mar-29-18 05:28PM  PR Newswire]
▶ Teflon maker Chemours sees more profit in 2018   [Mar-26-18 05:14PM  MarketWatch]
▶ Top Ranked Value Stocks to Buy for March 16th   [Mar-16-18 07:50AM  Zacks]
Financial statements of CC
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.